drugset / Trial / NCT03313726

The Effect of ADT on PSMA-PET.

NCT03313726

Unknown 30 enrolled Turku University Hospital
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

Phase A: To describe and to determine the maximum standardised uptake values (SUV) in prostate specific membrane antigen positron emission tomography (PSMA-PET) before ADT and 7, 14 and 28 days after ADT. Phase B: To validate phase A results by comparing the PSMA-PET findings to histopathological analysis of regional lymph nodes acquired from radical prostatectomy specimens. PSMA-PET is done before ADT and at maximum SUV defined by the phase A.

Timeline

Start
2017-09-20
Primary completion
2018-09-30
Completion
2018-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Degarelix Other / unclassified

Indications